Results 241 to 250 of about 2,801,899 (401)
Red‐light‐activated Ir1 overcomes hypoxia tolerance and adapts to the immunosuppressive tumor microenvironment, converting immunologically cold tumors into inflamed hot microenvironments. This conversion is driven by synergistic induction of immunogenic cell death through coordinated ferroptosis‐necroptosis pathways and spatiotemporally controlled ...
Long‐Bo Yu +8 more
wiley +1 more source
Adenosine receptor subtype modulators: Insight into molecular mechanisms and their therapeutic application. [PDF]
Solanki N +14 more
europepmc +1 more source
Molecular Determinants of CGS21680 Binding to the Human Adenosine A2A Receptor
G. Lebon, P. Edwards, A. Leslie, C. Tate
semanticscholar +1 more source
Radiotherapy induces tumor cells to release microparticles (RT‐MPs) into the circulation. The mitochondrial DNA carried by these RT‐MPs activates the STING/NLRP3/GSDMD axis in splenic neutrophils, triggering IL‐1β secretion. This, in turn, enhances dendritic cell function and facilitates the formation of cytotoxic T lymphocytes, thereby promoting ...
Yan Hu +18 more
wiley +1 more source
Adenosine Receptor Mechanisms Underlying Bladder Dysfunction in Male Rats With Bladder Outlet Obstruction. [PDF]
Takaoka EI +7 more
europepmc +1 more source
A<sub>2A</sub> adenosine receptor agonists, antagonists, inverse agonists and partial agonists. [PDF]
Jacobson KA, Suresh RR, Oliva P.
europepmc +1 more source
Unraveling the role adenosine A2A receptors on alpha-synuclein-mediated neurotoxicity
Diana G. Ferreira
openalex +2 more sources
Resorbable impedance sensors are successfully implanted into porcine small intestinal anastomoses. Impedance was recorded for 2 hours prior, and 2 hours following ischemia induction, and a significant drop in tissue impedance was observed. Abstract Anastomotic failure remains one of the most severe complications in gastrointestinal surgery.
Dennis Wahl +12 more
wiley +1 more source
A new approach to psoriasis therapy: photoswitchable A<sub>3</sub> adenosine receptor activation. [PDF]
Cherchi F, Coppi E.
europepmc +1 more source
Improving combination therapies: targeting A2B-adenosine receptor to modulate metabolic tumor microenvironment and immunosuppression. [PDF]
Evans JV +32 more
europepmc +1 more source

